National Pharmaceutical Congress (NPC) Podcast

10 Jul 2025 12:42

S14 E02 Developing Disease Modifying Therapeutics for ALS at Neuropeutics

Marc Shenouda, CEO and Co-Founder of Neuropeutics Inc., gives insights into targeted therapeutics for neurodegenerative disease, winning the AbbVie Biotech Innovator’s Award, and earlier detection for ALS.

Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe

Отзывы

Podcastly – the best platform for podcasters and podcast lovers. More than 10 millions of audio content that available on Android/iOS/Web/Desktop and Telegram.

Social networks

Select language

🇺🇸